Taurog J D, Maika S D, Simmons W A, Breban M, Hammer R E
Harold C. Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, Dallas 75235.
J Immunol. 1993 May 1;150(9):4168-78.
To investigate the role of the class I MHC molecule HLA-B27 in the spondyloarthropathies, we produced rats transgenic for HLA-B27 and human beta 2-microglobulin. Of five lines bearing > 1 copy of each transgene and showing hemizygous expression of both transgenes, two (lines 21-4H and 33-3) developed spontaneous inflammatory disease that closely resembled B27-associated human disease. Two lines, 21-4L and 25-6, remained healthy even when homozygous for the transgene locus, whereas the 21-3 line, bearing the third highest transgene copy number, developed disease similar to that of the 21-4H and 33-3 lines only when homozygous for the transgene locus. The disease-prone lines showed higher expression of B27--thymic mRNA in utero, splenic mRNA by 5 days of age, and splenic cell surface protein by the time of disease onset--than the disease-resistant lines. Disease susceptibility thus appeared to correlate with gene copy number and the quantity of B27 in lymphoid cells. The increase in the amount of B27 protein did not appear to be simply a consequence of the inflammatory disease because 1) there was no similar change in endogenous RT1 class I expression; 2) no alteration of B27 expression occurred in 21-4H rats with adjuvant-induced arthritis; 3) in rats with inflammatory disease transgenic for HLA-A2 and the 21-4H transgene locus, A2 expression was the same as in healthy rats transgenic for A2 but not B27; and 4) the transgenes in disease-prone and disease-resistant lines were equally susceptible to induction by IFN-gamma. Immunocytochemistry of the distal colon, an early site of inflammation, showed that the B27 Ag is expressed at high levels in cells of the lamina propria, but not at all in colonic epithelial cells. Taken together, the data suggest that the B27 transgene is expressed in a copy number dependent, position-independent manner in lymphoid tissue and that disease results from the expression of B27 above a critical threshold level.
为了研究I类主要组织相容性复合体分子HLA - B27在脊柱关节病中的作用,我们制备了转HLA - B27和人β2 - 微球蛋白基因的大鼠。在携带每个转基因>1个拷贝且显示两个转基因半合子表达的5个品系中,有两个品系(21 - 4H和33 - 3)发生了与B27相关的人类疾病极为相似的自发性炎症性疾病。两个品系,21 - 4L和25 - 6,即使在转基因位点纯合时仍保持健康,而携带第三高转基因拷贝数的21 - 3品系,只有在转基因位点纯合时才会发生与21 - 4H和33 - 3品系相似的疾病。与抗病品系相比,易发病品系在子宫内B27 - 胸腺mRNA表达较高,5日龄时脾脏mRNA表达较高,疾病发作时脾脏细胞表面蛋白表达较高。因此,疾病易感性似乎与基因拷贝数和淋巴样细胞中B27的量相关。B27蛋白量的增加似乎并非仅仅是炎症性疾病的结果,因为:1)内源性RT1 I类表达没有类似变化;2)在佐剂诱导性关节炎的21 - 4H大鼠中,B27表达没有改变;3)在转HLA - A2和21 - 4H转基因位点的炎症性疾病大鼠中,A2表达与转A2但不转B27的健康大鼠相同;4)易发病和抗病品系中的转基因对IFN - γ诱导的敏感性相同。对远端结肠(炎症早期部位)进行免疫细胞化学分析显示,B27抗原在固有层细胞中高水平表达,但在结肠上皮细胞中完全不表达。综上所述,数据表明B27转基因在淋巴组织中以拷贝数依赖性、位置非依赖性方式表达,且疾病是由B27表达超过临界阈值水平所致。